Renaissance Technologies’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-24,560
| Closed | -$49.1K | – | 3515 |
|
|
2025
Q4 | $49.1K | Buy |
+24,560
| New | +$58.2K | ﹤0.01% | 3094 |
|
|
2025
Q1 | – | Sell |
-105,658
| Closed | -$118K | – | 3690 |
|
|
2024
Q4 | $118K | Buy |
+105,658
| New | +$103K | ﹤0.01% | 3263 |
|
|
2024
Q3 | – | Sell |
-29,295
| Closed | -$29.9K | – | 3746 |
|
|
2024
Q2 | $29.9K | Sell |
29,295
-52,412
| -64% | -$53.9K | ﹤0.01% | 3343 |
|
|
2024
Q1 | $100K | Sell |
81,707
-24,288
| -23% | -$30.8K | ﹤0.01% | 3368 |
|
|
2023
Q4 | $174K | Sell |
105,995
-17,599
| -14% | -$23.4K | ﹤0.01% | 3179 |
|
|
2023
Q3 | $172K | Buy |
123,594
+35,899
| +41% | +$77.9K | ﹤0.01% | 3129 |
|
|
2023
Q2 | $239K | Buy |
87,695
+67,300
| +330% | +$135K | ﹤0.01% | 3227 |
|
|
2023
Q1 | $42K | Buy |
20,395
+2,400
| +13% | +$7.1K | ﹤0.01% | 3696 |
|
|
2022
Q4 | $54K | Sell |
17,995
-1,100
| -6% | -$4.56K | ﹤0.01% | 3782 |
|
|
2022
Q3 | $91K | Sell |
19,095
-1,000
| -5% | -$5.14K | ﹤0.01% | 3623 |
|
|
2022
Q2 | $103K | Buy |
20,095
+4,400
| +28% | +$24.5K | ﹤0.01% | 3843 |
|
|
2022
Q1 | $98K | Buy |
15,695
+5,400
| +52% | +$31.6K | ﹤0.01% | 3797 |
|
|
2021
Q4 | $77K | Buy |
+10,295
| New | +$66.3K | ﹤0.01% | 3728 |
|
|
2021
Q3 | – | Sell |
-40,113
| Closed | -$318K | – | 3692 |
|
|
2021
Q2 | $318K | Buy |
+40,113
| New | +$303K | ﹤0.01% | 3128 |
|
|
2021
Q1 | – | Sell |
-16,200
| Closed | -$112K | – | 3549 |
|
|
2020
Q4 | $112K | Buy |
+16,200
| New | +$122K | ﹤0.01% | 3248 |
|
|
2020
Q3 | – | Sell |
-35,400
| Closed | -$245K | – | 3551 |
|
|
2020
Q2 | $245K | Sell |
35,400
-79,513
| -69% | -$538K | ﹤0.01% | 3108 |
|
|
2020
Q1 | $638K | Sell |
114,913
-73,862
| -39% | -$647K | ﹤0.01% | 2644 |
|
|
2019
Q4 | $1.92M | Sell |
188,775
-12,774
| -6% | -$74.9K | ﹤0.01% | 2349 |
|
|
2019
Q3 | $1.07M | Sell |
201,549
-5,338
| -3% | -$31.2K | ﹤0.01% | 2567 |
|
|
2019
Q2 | $1.06M | Buy |
206,887
+10,838
| +6% | +$71.8K | ﹤0.01% | 2647 |
|
|
2019
Q1 | $1.52M | Buy |
196,049
+127,200
| +185% | +$989K | ﹤0.01% | 2467 |
|
|
2018
Q4 | $118K | Buy |
+68,849
| New | +$260K | ﹤0.01% | 3211 |
|
|
2016
Q4 | – | Sell |
-1,520
| Closed | -$279K | – | 3365 |
|
|
2016
Q3 | $279K | Buy |
1,520
+980
| +181% | +$128K | ﹤0.01% | 2983 |
|
|
2016
Q2 | $29K | Buy |
540
+383
| +244% | +$110K | ﹤0.01% | 3267 |
|
|
2016
Q1 | $66K | Buy |
157
+42
| +37% | +$22.2K | ﹤0.01% | 3253 |
|
|
2015
Q4 | $77K | Buy |
115
+55
| +92% | +$40.4K | ﹤0.01% | 3135 |
|
|
2015
Q3 | $39K | Buy |
+60
| New | +$45.6K | ﹤0.01% | 3091 |
|
|
2015
Q1 | – | Sell |
-30
| Closed | -$45K | – | 3270 |
|
|
2014
Q4 | $45K | Sell |
30
-7
| -19% | -$12.7K | ﹤0.01% | 2883 |
|
|
2014
Q3 | $76K | Buy |
+37
| New | +$97.6K | ﹤0.01% | 2688 |
|
Other funds holding MBOT
VCM
CBU
AA
Renaissance Technologies's MBOT Position: Q1 2026 in Review
Renaissance Technologies sold out of Microbot Medical (MBOT) in Q1 2026, closing a stake of 24,560 shares — an estimated $49.1K sold.
Renaissance Technologies first reported a position in MBOT in Q3 2014 and held it in 29 quarters. The position peaked at $1.92M in Q4 2019. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.
- Renaissance Technologies reported no remaining Microbot Medical position as of Q1 2026 after selling out during the quarter.
- Renaissance Technologies sold 24,560 Microbot Medical shares in Q1 2026, an estimated $49.1K.
- Renaissance Technologies first reported a position in Microbot Medical in Q3 2014 and held it in 29 quarters.
- Renaissance Technologies's Microbot Medical position peaked at $1.92M in Q4 2019.
- 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.